[go: up one dir, main page]

WO2008117091A3 - Treatments for bacterial, parasitic, fungal and prionic infections - Google Patents

Treatments for bacterial, parasitic, fungal and prionic infections Download PDF

Info

Publication number
WO2008117091A3
WO2008117091A3 PCT/GB2008/050215 GB2008050215W WO2008117091A3 WO 2008117091 A3 WO2008117091 A3 WO 2008117091A3 GB 2008050215 W GB2008050215 W GB 2008050215W WO 2008117091 A3 WO2008117091 A3 WO 2008117091A3
Authority
WO
WIPO (PCT)
Prior art keywords
fungal
parasitic
bacterial
treatments
prionic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2008/050215
Other languages
French (fr)
Other versions
WO2008117091A2 (en
Inventor
Richard George Stead
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA002682145A priority Critical patent/CA2682145A1/en
Priority to EP08719060A priority patent/EP2124971A2/en
Publication of WO2008117091A2 publication Critical patent/WO2008117091A2/en
Publication of WO2008117091A3 publication Critical patent/WO2008117091A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/16—Fluorine compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01C—AMMONIA; CYANOGEN; COMPOUNDS THEREOF
    • C01C3/00—Cyanogen; Compounds thereof
    • C01C3/20—Thiocyanic acid; Salts thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)

Abstract

A treatment for an infection, the treatment comprising the products formed from a peroxidase catalysed reaction between an oxidisable species and at least one oxygen donor, in aqueous solution; wherein the original enzyme has been removed therefrom.
PCT/GB2008/050215 2007-03-23 2008-03-25 Treatments for bacterial, parasitic, fungal and prionic infections Ceased WO2008117091A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA002682145A CA2682145A1 (en) 2007-03-23 2008-03-25 A treatment
EP08719060A EP2124971A2 (en) 2007-03-23 2008-03-25 Treatments for bacterial, parasitic, fungal and prionic infections

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0705557.7 2007-03-23
GBGB0705557.7A GB0705557D0 (en) 2007-03-23 2007-03-23 A treatment

Publications (2)

Publication Number Publication Date
WO2008117091A2 WO2008117091A2 (en) 2008-10-02
WO2008117091A3 true WO2008117091A3 (en) 2009-04-23

Family

ID=38024667

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/GB2008/050213 Ceased WO2008117089A2 (en) 2007-03-23 2008-03-25 Treatments for viral infections
PCT/GB2008/050215 Ceased WO2008117091A2 (en) 2007-03-23 2008-03-25 Treatments for bacterial, parasitic, fungal and prionic infections

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/GB2008/050213 Ceased WO2008117089A2 (en) 2007-03-23 2008-03-25 Treatments for viral infections

Country Status (4)

Country Link
EP (1) EP2124971A2 (en)
CA (1) CA2682145A1 (en)
GB (1) GB0705557D0 (en)
WO (2) WO2008117089A2 (en)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986007264A1 (en) * 1985-06-14 1986-12-18 Kellway Pharmaceuticals Limited Contact lens cleaning and disinfection
EP0745327A1 (en) * 1995-05-29 1996-12-04 Symbollon Corporation Method for inactivating pathogens
WO1997026908A1 (en) * 1996-01-23 1997-07-31 Semper Aktiebolag Use of lactoperoxidase, a peroxide donor and thiocyanate for the manufacture of a medicament for treating helicobacter pylori infection
FR2798137A1 (en) * 1999-09-07 2001-03-09 Bonneau Marguerite Gabr Calone GENERATING APPARATUS FOR OXYGENIC CHEMICAL RADICALS AND INDUSTRIAL APPLICATIONS
WO2001028600A1 (en) * 1999-10-20 2001-04-26 Oxibio, Inc. Conveyance of anti-infective activity to wound dressings
WO2002069958A1 (en) * 2001-03-01 2002-09-12 Wolfgang Weuffen Thiocyanate ions for preventing and treating bse and similar animal and human diseases
US20020172645A1 (en) * 2001-05-15 2002-11-21 Conner Gregory E. Novel methods and devices for treating lung dysfunction
WO2002097076A1 (en) * 2001-05-31 2002-12-05 Tmi Europe Method for the enzymatic production of a curing agent in its fluid state

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9015910D0 (en) * 1990-07-19 1990-09-05 Univ Bruxelles Novel use
JP4355592B2 (en) * 2004-02-23 2009-11-04 森永乳業株式会社 Antiviral agent

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986007264A1 (en) * 1985-06-14 1986-12-18 Kellway Pharmaceuticals Limited Contact lens cleaning and disinfection
EP0745327A1 (en) * 1995-05-29 1996-12-04 Symbollon Corporation Method for inactivating pathogens
WO1997026908A1 (en) * 1996-01-23 1997-07-31 Semper Aktiebolag Use of lactoperoxidase, a peroxide donor and thiocyanate for the manufacture of a medicament for treating helicobacter pylori infection
FR2798137A1 (en) * 1999-09-07 2001-03-09 Bonneau Marguerite Gabr Calone GENERATING APPARATUS FOR OXYGENIC CHEMICAL RADICALS AND INDUSTRIAL APPLICATIONS
WO2001028600A1 (en) * 1999-10-20 2001-04-26 Oxibio, Inc. Conveyance of anti-infective activity to wound dressings
WO2002069958A1 (en) * 2001-03-01 2002-09-12 Wolfgang Weuffen Thiocyanate ions for preventing and treating bse and similar animal and human diseases
US20020172645A1 (en) * 2001-05-15 2002-11-21 Conner Gregory E. Novel methods and devices for treating lung dysfunction
WO2002097076A1 (en) * 2001-05-31 2002-12-05 Tmi Europe Method for the enzymatic production of a curing agent in its fluid state

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SMITH R P: "Cyanate and thiocyanate: acute toxicity", PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE 1973, vol. 142, no. 3, 1973, pages 1041 - 1044, XP008103040, ISSN: 0037-9727 *

Also Published As

Publication number Publication date
WO2008117089A3 (en) 2009-04-23
CA2682145A1 (en) 2008-10-02
GB0705557D0 (en) 2007-05-02
WO2008117091A2 (en) 2008-10-02
EP2124971A2 (en) 2009-12-02
WO2008117089A2 (en) 2008-10-02

Similar Documents

Publication Publication Date Title
WO2007030567A3 (en) Pparactive compounds
WO2008041966A3 (en) Broad spectrum antibacterial compounds
WO2007118130A3 (en) Antibacterial agents
WO2006099359A3 (en) Methods of reducing microbial contamination
WO2008109697A3 (en) Ppar active compounds
WO2008054676A3 (en) Medical devices and methods of using the same
WO2007097985A8 (en) Catheter cleaning devices
MY176503A (en) Hypoglycemic effect enhancer
WO2006013441A3 (en) Use of probiotic bacteria for the preparation of topical compositions for skin protection
MX2011008920A (en) Otic compositions useful for the treatment of infections of the internal and external ear in mammals.
AU2005235116A1 (en) Combinations for treating HIV infection
WO2011071904A3 (en) Inhibiting bacterial infection and biofilm formation
WO2010040952A3 (en) Reaction medium for staphylococcus aureus bacteria
TW200738166A (en) Method for processing sprouted cereal, malt product, fermented malt drink and food and drink
WO2006111681A3 (en) Arrangement for sterilising objects by electron bombardment
WO2010040126A3 (en) Sterile liquid transfer port
WO2006081182A3 (en) Antibacterial agents
WO2009103140A3 (en) Bottle
WO2010117718A3 (en) Dual sided workpiece handling
WO2006081178A3 (en) Antibacterial agents
WO2007121257A3 (en) Implicitly timed gear bearings
WO2007019178A3 (en) Corn protein concentrates
WO2006034035A3 (en) Treatment of ischemia
WO2007046890A8 (en) Lozenge for treatment of dry mouth and related conditions
WO2008117091A3 (en) Treatments for bacterial, parasitic, fungal and prionic infections

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08719060

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2008719060

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2682145

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE